Obesity and cancer: The risks, science, and potential management strategies

被引:0
|
作者
McTiernan, Anne [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Prevent Ctr, Seattle, WA 98109 USA
来源
ONCOLOGY-NEW YORK | 2005年 / 19卷 / 07期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overweight and obesity increase the risk of developing several cancers. Once cancer develops, individuals may be at increased risk of recurrence and poorer survival if they are overweight or obese. A statistically significant association between overweight or obesity and breast cancer recurrence or survival has been observed in the majority of population based case series; however, adiposity has been shown to have less of an effect on prognosis in the clinical trial setting. Weight gain after breast cancer diagnosis may also be associated with decreased prognosis. New evidence suggests that overweight/obesity vs normal weight may increase the risk of poor prognosis among resected colon cancer patients and the risk of chemical recurrence in prostate cancer patients. Furthermore, obese cancer patients are at increased risk for developing problems following surgery, including wound complication, lymphedema, second cancers, and the chronic diseases affecting obese individuals without cancer such as cardiovascular disease and diabetes. Mechanisms proposed to explain the association between obesity and reduced prognosis include adipose tissue-induced increased concentrations of estrogens and testosterone, insulin, bioavailable insulin-like growth factors, leptin, and cytokines. Additional proposed mechanisms include reduced immune functioning, chemotherapy dosing, and differences in diet and physical activity in obese and nonobese patients. There have been no randomized clinical trials testing the effect of weight loss on recurrence or survival in overweight or obese cancer patients, however. In the absence of clinical trial data, normal weight, overweight, and obese patients should be advised to avoid weight gain through the cancer treatment process. In addition, weight loss is probably safe, and perhaps helpful, for overweight and obese cancer survivors who are otherwise healthy.
引用
收藏
页码:871 / 881
页数:11
相关论文
共 50 条
  • [31] Incomplete Data and Potential Risks of Drugs in People with Obesity
    Caroline M. Apovian
    Christopher D. Bruno
    Theodore K. Kyle
    Christina R. Chow
    David J. Greenblatt
    Current Obesity Reports, 2023, 12 : 429 - 438
  • [32] Organ Transplantation and Obesity: Evaluation, Risks and Benefits of Therapeutic Strategies
    H Weiss
    H Nehoda
    B Labeck
    M Oberwalder
    F Aigner
    A Königsrainer
    R Margreiter
    Obesity Surgery, 2000, 10 : 465 - 469
  • [33] Incomplete Data and Potential Risks of Drugs in People with Obesity
    Apovian, Caroline
    Bruno, Christopher
    Kyle, Theodore
    Chow, Christina
    Greenblatt, David
    OBESITY, 2023, 31 : 276 - 277
  • [34] Weighing your risks: Obesity and ovarian cancer
    Hijaz, M.
    Rasool, N.
    Munkarah, A. R.
    Rattan, R.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 202 - 202
  • [35] Obesity's risks include cancer, too
    Steinberg, D
    SCIENTIST, 2003, 17 (06): : 28 - 29
  • [36] Prehypertension—prevalence, health risks, and management strategies
    Brent M. Egan
    Sean Stevens-Fabry
    Nature Reviews Cardiology, 2015, 12 : 289 - 300
  • [37] Arsenic in the environment-risks and management strategies
    Naidu, Ravi
    Bhattacharya, Prosun
    ENVIRONMENTAL GEOCHEMISTRY AND HEALTH, 2009, 31 : 1 - 8
  • [38] Cancer in the family: risks and management
    Kirk, J
    Kefford, R
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (11) : 529 - 530
  • [39] Obesity epidemic: Pathogenesis, health risks, and comprehensive management
    Hainer, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 5 - 5
  • [40] Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer
    Dasari, Shaloam
    Yedjou, Clement G.
    Brodell, Robert T.
    Cruse, Allison R.
    Tchounwou, Paul B.
    NANOTECHNOLOGY REVIEWS, 2020, 9 (01) : 1500 - 1521